Addressing Radiation Access Disparities in Hispanic Breast Cancer Patients
We are investigating novel strategies to ensure that Hispanic Americans with breast cancer receive the best possible treatment. Hispanic Americans are less likely to have breast conserving surgery and radiation therapy for early-stage breast cancer than Caucasians and have an increased risk of experiencing delays between surgery and radiation treatment. We have launched the Navigator-Assisted Hypofractionation (NAVAH) program to address disparities in breast cancer care through navigators who support patients by helping to ensure they complete their treatment and to limit the financial toxicity of their care. Building on the NAVAH program that we established for African American breast cancer patients, we are working with community partners to tailor the experience for Hispanic Americans based on language and culture. Our work represents the first randomized controlled trial on the impact of patient navigation on radiation therapy treatment completion and financial toxicity in Hispanic American breast cancer patients.
